First treatment for common bladder cancer recommended by NICE - PharmaTimes Johnson & Johnson’s Balversa was found to extend the lives of urothelial cancer patients with a genetic alteration

#bladdercancer #NICErecommended #JnJ #Balversa #urothelialcancer #geneticalteration #erdafitinib #FGFR3alteration #unresectableurothelialcancer #metastaticurothelialcancer #THOrclinicaltrial #FGFR3expressingcancercellgrowth #genetictesting
pharmatimes.com/news/first-t...